期刊文献+

治疗类风湿关节炎的特色中药分析 被引量:1

Analysis to Characteristic Chinese Medicines for Treating Rheumatoid Arthritis
原文传递
导出
摘要 目的通过对现代医家运用中医治疗类风湿关节炎的系列方刹进行归纳性的回顾,探讨其治疗的特色药物,以期为研发治疗类风湿关节炎的新药提供思路。方法从近二十年核心医学期刊和相关的中医药书籍巾,收集中医治疗类风湿关节炎的组方340首。依据中医病因病机学、方药学理论,结合现代研究成果,统计分析所用药物。结果在治疗类风湿关节炎所用的254种中药中,虫类药和藤类药共32种,使用频次为806次。结论虫类药、藤类药与其他药配伍治疗类风湿关节炎运用频次较高、疗效良好。 Objective By studying the prescriptions and medicines for treating rheumatoid arthritis (RA) prescribed by modem doctors, we tried to provide new ideas for developing the new medicines for treating rheumatoid arthritis. Methods 340 prescriptions on treating rheumatoid arthritis were collected from core medical periodicals and books published in the recent 20 years. Make a statistical analysis to the medicines in these prescriptions according to TCM etiological and pharmaceutical theories and modem researching foundlings. Results Among all 254 Chinese medicines used for treating RA, 32 medicines belong to worm and vine medicines, being used for 806 times. Conclusion The worm and vine medicines are frequently used in treating RA with good therapeutic effects combined with other kinds of medicines.
出处 《国际中医中药杂志》 2009年第6期548-549,共2页 International Journal of Traditional Chinese Medicine
关键词 类风湿关节炎 虫类药 藤类药 Rheumatoid arthritis Worm medicines: Vine medicines
  • 相关文献

参考文献4

二级参考文献5

共引文献79

同被引文献24

  • 1侯立飞,赵伯涛,戴岳.中药有效成分治疗类风湿关节炎研究进展[J].中国野生植物资源,2005,24(5):8-11. 被引量:6
  • 2王亮,卓光生.类风湿关节炎血液学改变机制的研究进展[J].医学综述,2006,12(4):205-207. 被引量:10
  • 3李瑞,孟庆刚.类风湿性关节炎的临床治疗研究[J].中华中医药学刊,2007,25(7):1348-1352. 被引量:35
  • 4温成平,金晨宇,许志良,曹灵勇.解毒通络利湿方及拆方对实验性类风湿性关节炎抗炎镇痛及调节免疫作用的比较研究[J].中国中药杂志,2007,32(13):1306-1310. 被引量:13
  • 5Alamanos Y,Voulgari P V,Drosos A A, et al. Incidence and prevalenceof rheumatoid arthritis, based on the 1987 american college of rheuma-tology criteria: A systematic review [J].Eminars Arthritis Rheum,2006,33(2):182-188.
  • 6Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classifi-cation criteria: an american college of rheumatology/european league a-gainst rheumatism collaborative initiative [J]. Arthitis Rheum, 2010,62(9): 2569-2581.
  • 7Ahmad SF, Zoheir KM, Abdel -Hamied HE, et al. Amelioration of au-toimmune arthritis by naringin through modulation of T regulatory cellsand Thl/Th2 cytokines [J]. Cell Immunol, 2014, 287(2): 112-120.
  • 8Pujari R, Eligar SM, Kumar N, et al. CD45-mediated signaling pathwayis involved in Rhizoctonia bataticola lectin (RBL)-induced proliferationand Thl/Th2 cytokine secretion in human PBMC [J]. Biochem BiophysRes Commun’ 2012, 419(4): 708-714.
  • 9Herman S, Zurgil N, Machlav S, et al. Distinct effects of anti -tumornecrosis factor combined therapy on TH1/TH2 balance in rheumatoidarthritis patients [J]. Clin Vaccine Immunol, 2011,18(7): 1077-1082.
  • 10Scarsi M,Paolini L, Ricotta D, et al. Abatacept reduces levels of switchedmemory B cells, autoantibodies, and immunoglobulins in patients withrheumatoid arthritis [J]. J Rheumatol, 2014,41(4): 666-672.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部